Biotechnology News
Press Releases from Biotechnology Companies
Newsroom
Biotechnology news releases from biotechnology companies published by Newsfile. Searches will return results from stories up to two years old.
-
Therma Bright Enters into Clinical Trial Agreement for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - February 26, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has entered into an agreement with a COVID-19 testing site located in the Greater Toronto Area to conduct a clinical study...
Technology, Biotechnology, Health
2021-02-26 9:13 AM ET | Therma Bright Inc. -
iCo Therapeutics Inc: Unaware of Any Material Change
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2021) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company"). At the request of IIROC, iCo Therapeutics Inc. (the "Company") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account...
Biotechnology, Pharmaceuticals, Health
2021-02-25 3:13 PM ET | iCo Therapeutics Inc. -
Portage Commences Trading on Nasdaq
Toronto, Ontario--(Newsfile Corp. - February 25, 2021) - Portage Biotech Inc. (CSE: PBT.U) (NASDAQ: PRTG) ("Portage" or the "Company") a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the commencement of trading of its ordinary shares on the NASDAQ Capital Market ("Nasdaq") under the...
Biotechnology, Pharmaceuticals
2021-02-25 8:00 AM ET | Portage BioTech Inc. -
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy
Toronto, Ontario--(Newsfile Corp. - February 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce it has expanded...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-02-25 7:33 AM ET | Pharmadrug Inc. -
Relay Medical & Fio Corporation to Deploy Fionet COVID-19 Rapid Testing Platform at Toronto Pearson International Airport
Toronto, Ontario--(Newsfile Corp. - February 24, 2021) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and Fio Corporation ("Fio") - together Fionet Rapid Response Group ("FRR") - are pleased to announce that the Greater Toronto Airports Authority (GTAA) has engaged FRR to deploy the...
Biotechnology, Healthcare and Hospitals, Health
2021-02-24 1:31 PM ET | Relay Medical Corp. -
Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, provides a production update on HaluGen Life Sciences Inc. ("HaluGen"), a wholly-owned subsidiary of Entheon, which is in the...
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2021-02-24 8:30 AM ET | Entheon Biomedical Corp. -
MustGrow Receives Registration Approval for Powdery Mildew Bio-Fungicide
Regulatory approval received in Canada.Bio-fungicide product for powdery mildew suppression treatment on cannabis and hemp.Product is licensed exclusively from leading multinational biological company.Saskatoon, Saskatchewan--(Newsfile Corp. - February 24, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the "Company", "MustGrow") is pleased to announce
Biotechnology, Cannabis, Cannabis Breeder, Cannabis Cultivator
2021-02-24 7:02 AM ET | MustGrow Biologics Corp. -
Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference
La Jolla, California--(Newsfile Corp. - February 24, 2021) - Tryp Therapeutics (CSE: TRYP) ("Tryp" or the "Company") a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today the company has been invited to present at the Stifel GMP Healthcare Conference: Healthcare...
Biotechnology, Pharmaceuticals
2021-02-24 7:00 AM ET | Tryp Therapeutics Inc. -
Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Linnéa Olofsson as an advisor and consultant for the Company.Dr. Olofsson will be working with our team in implementing our strategies...
Biotechnology, Pharmaceuticals, Health
2021-02-23 8:00 AM ET | PreveCeutical Medical Inc. -
American Aires Launch a Recurring Revenue Subscription Model for Product Sales
Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - American Aires Inc. (CSE: WIFI) (the "Company" or "Aires"), is excited to launch an additional purchasing option for customers through the implementation of a multi-year subscription plan for Aires products. The subscription option will be available to customers beginning in March. This...
Technology, Biotechnology
2021-02-22 8:30 AM ET | American Aires Inc. -
Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTC: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced ethics approval for an upcoming pre-clinical study to be conducted by the clinical research organization, Science...
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2021-02-22 8:30 AM ET | Entheon Biomedical Corp. -
Mindset Pharma Reaches Agreement to Manufacture Large Quantity of Pharmaceutical Grade Psilocybin Using Patent-Pending Synthesis Process
Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) ("Mindset" or the "Company"), a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that it has engaged a leading international contract development and manufacturing...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-02-22 7:00 AM ET | Mindset Pharma Inc. -
Izotropic präsentiert neue Website und Unternehmenspräsentation
Vancouver, British Columbia--(Newsfile Corp. - Freitag, 19. Februar 2021) - Izotropic Corporation ("Izotropic" oder das "Unternehmen") (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) vermarktet echte, dedizierte 3D-Brust-CT-Bildgebungstechnologie für die frühere Erkennung, Diagnose und Behandlung von Brustkrebs. Das Unternehmen freut sich bekannt zu geben, dass es eine aktualisierte
Biotechnology, Health
2021-02-19 10:53 AM ET | Izotropic Corporation -
Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World's First 'MDMA in Alcohol Use Disorder' Clinical Trial
London, United Kingdom--(Newsfile Corp. - February 19, 2021) - Awakn Life Sciences Inc. announces today the publication of results from its CMO Dr. Ben Sessa's Bristol Imperial MDMA in Alcoholism (BIMA) trial, an open-label safety, tolerability and proof-of-concept study investigating the potential role for MDMA-Assisted Psychotherapy in treating patients with...
Biotechnology, Healthcare and Hospitals, Health
2021-02-19 8:59 AM ET | Awakn Life Sciences Inc. -
Izotropic Launches New Website and Corporate Presentation
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing true 3D, dedicated breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancers, is pleased to announce it has launched an...
Biotechnology, Health
2021-02-19 8:00 AM ET | Izotropic Corporation -
Mindset Pharma Added to North American Psychedelics Index
Toronto, Ontario--(Newsfile Corp. - February 19, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) ("Mindset" or the "Company"), a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that effective today, it has been added to the North American...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-02-19 7:00 AM ET | Mindset Pharma Inc. -
Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.'s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute
Toronto, Ontario--(Newsfile Corp. - February 18, 2021) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") is pleased to announce that it has completed an investment in ISBRG Corp. ("ISBRG") for a minority interest, and secured agency rights to their SpotLight-19© Technology. ISBRG is a data analytics company...
Biotechnology, Environmental Services, Energy, Utilities
2021-02-18 9:42 AM ET | Universal PropTech Inc. -
Tryp Therapeutics Completes $2 Million Strategic Financing
La Jolla, California--(Newsfile Corp. - February 17, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp"), a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, is pleased to announce that effective February 16, 2021, it has closed its previously announced financing (see news...
Biotechnology, Pharmaceuticals
2021-02-17 5:38 PM ET | Tryp Therapeutics Inc. -
American Aires Launches Innovative Marketing Strategy for 2021
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - American Aires Inc. (CSE: WIFI) (the "Company" or "Aires") is pleased to announce the immediate implementation of an innovative new marketing initiative for 2021, comprised of a drop shipping program which includes online retailers and a complementary marketing campaign.This program will enable...
Technology, Biotechnology
2021-02-17 8:30 AM ET | American Aires Inc. -
Mindset Pharma Announces U.S. Listing Application for OTCQB Venture Market
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTC PINK: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that it has applied to the OTC Markets...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-02-17 7:00 AM ET | Mindset Pharma Inc.